Exact Mass: 287.1957
Exact Mass Matches: 287.1957
Found 86 metabolites which its exact mass value is equals to given mass value 287.1957,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Arginylleucine
Arginylleucine is a dipeptide composed of arginine and leucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
N-[2-(4-Prenyloxyphenyl)ethyl]tiglamide
N-[2-(4-Prenyloxyphenyl)ethyl]tiglamide is a constituent of Boronia megastigma (brown boronia). Constituent of Boronia megastigma (brown boronia)
Leucyl-Arginine
Leucyl-Arginine is a dipeptide composed of leucine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Arginylisoleucine
Arginylisoleucine is a dipeptide composed of arginine and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Isoleucyl-Arginine
Isoleucyl-Arginine is a dipeptide composed of isoleucine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
(2S)-1-[2-(2-Adamantylamino)acetyl]pyrrolidine-2-carbonitrile
N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]-N-methyl-2-methylpropanamide
N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]-3-methylbutanamide
(2S)-3-(2,3-Dihydroxy-3-methylbutyl)-6-(3-methyl-2-butenyl)indole|3-Methyl-1-[6-(3-methyl-2-butenyl)-1H-indol-3-yl]-2,3-butanediol
(n-Nonanol-9)-2-chinolon-4|2-(9-hydroxy-nonyl)-1H-quinolin-4-one
(2R)-3-(1,3-Dihydroxy-3-methylbut-2-yl)-6-(3-methyl-2-butenyl)indole|3-Methyl-2-[6-(3-methyl-2-butenyl)-1H-indol-3-yl]-1,3-butanediol
(E,E)-2,4-decadienoic acid p-hydroxyphenethylamide|Deca-2t,4t-diensaeure-(4-hydroxyphenyl-aethyl)-amid
PQS-C9 and NQNO mixture, 2-nonyl-3-hydroxy 4(1H)-quinolone
Arg-ile
A dipeptide formed from L-arginyl and L-isoleucine residues.
Arg-leu
A dipeptide formed from L-arginyl and L-leucine residues.
Ile-arg
A dipeptide formed from L-isoleucine and L-arginine residues.
Leu-arg
A dipeptide composed of L-leucine and L-arginine joined by peptide linkages.
